Could Sleep Affect Cancer Survival?

Cancer treatment may be missing one of the body’s most important biological signals: circadian rhythm. In this conversation, sleep neurologist Dr. Anne Marie Morse explains how sleep timing, inflammation, immune function, and wearable data could fundamentally reshape cancer care. Emerging research suggests the timing of immunotherapy, chemotherapy, and even sleep disruption itself may influence treatment response, survival, and recurrence risk. The discussion explores chronotherapy, circadian genes, microbiome interactions, and how AI-driven analytics may help clinicians move beyond episodic care toward continuous, personalized monitoring. Topics include: • Sleep and cancer biology • Circadian rhythm and immunotherapy response • Why treatment timing matters • AI, wearables, and predictive healthcare • Microbiome and immune system connections • Precision medicine beyond biomarkers As healthcare moves toward longitudinal AI-enabled care, understanding the body’s internal clock may become impossible to ignore. 👉 Subscribe for more conversations exploring AI, oncology, and the future of medicine. Hosts: Dr. Sanjay Juneja:   / sanjayjunejamd   Dr. Douglas Flora:   / douglasflora   Guest: Dr. Anne Marie Morse:   / anne-marie-morse-753b2821   - - -TimeStamps - - - - 00:00 Introduction 03:39 Circadian Genes Explained 07:52 Shift Work and Chronotherapy 10:18 Immunotherapy Timing Matters 15:02 Morse Background and Mission 20:21 Biomarkers Are a Lie 23:01 Sleep Regularity and Cancer 34:53 AI Wearables and Stewardship 46:27 Microbiome Feedback Loops #sleep #cancertreatment #oncology